Kyoto-McGill International Collaborative Program in Genomic Medicine Japan

Research

Date range: 1 June 2021 - 31 May 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Kyoto-McGill International Collaborative Program in Genomic Medicine published between 1 June 2021 - 31 May 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Kyoto-McGill International Collaborative Program in Genomic Medicine
Count Share
4 0.04

Outputs by subject (Share)

Outputs by subject
Subject Count Share
4 0.04

Share output for the past 5 years

Share per year
2017 2018 2019 2020 2021
0.00 0.01 0.06 0.09 0.03

Compare Kyoto-McGill International Collaborative Program in Genomic Medicine with other institutions

Collaboration

Date range: 1 June 2021 - 31 May 2022

International vs. domestic collaboration by Share

  • 2.13% Domestic
  • 97.87% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Kyoto-McGill International Collaborative Program in Genomic Medicine by Share (2 total)

  1. Kyoto-McGill International Collaborative Program in Genomic Medicine and Kyoto University (0.05)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.04
    Kyoto University0.02
  2. Kyoto-McGill International Collaborative Program in Genomic Medicine and Takeda Pharmaceutical Company Limited (0.05)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.00
    Takeda Pharmaceutical Company Limited0.05

Top 10 international collaborators with Kyoto-McGill International Collaborative Program in Genomic Medicine by Share (76 total)

  1. Kyoto-McGill International Collaborative Program in Genomic Medicine and University of Montreal (UdeM) (0.85)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.01
    University of Montreal (UdeM)0.84
  2. Kyoto-McGill International Collaborative Program in Genomic Medicine and Regeneron Pharmaceuticals, Inc. (0.44)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.00
    Regeneron Pharmaceuticals, Inc.0.43
  3. Kyoto-McGill International Collaborative Program in Genomic Medicine and McGill University (0.43)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.04
    McGill University0.40
  4. Kyoto-McGill International Collaborative Program in Genomic Medicine and Columbia University in the City of New York (CU) (0.26)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.03
    Columbia University in the City of New York (CU)0.23
  5. Kyoto-McGill International Collaborative Program in Genomic Medicine and The University of Edinburgh (0.18)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    The University of Edinburgh0.15
  6. Kyoto-McGill International Collaborative Program in Genomic Medicine and University of Pennsylvania (Penn) (0.18)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    University of Pennsylvania (Penn)0.15
  7. Kyoto-McGill International Collaborative Program in Genomic Medicine and Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC) (0.13)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC)0.12
  8. Kyoto-McGill International Collaborative Program in Genomic Medicine and U.S. Department of Veterans Affairs (0.12)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    U.S. Department of Veterans Affairs0.10
  9. Kyoto-McGill International Collaborative Program in Genomic Medicine and NHS Lothian (0.10)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    NHS Lothian0.07
  10. Kyoto-McGill International Collaborative Program in Genomic Medicine and Boston University (BU) (0.10)
    Kyoto-McGill International Collaborative Program in Genomic Medicine0.02
    Boston University (BU)0.08

Relationships

Partner Institutions

Kyoto-McGill International Collaborative Program in Genomic Medicine is a research collaboration whose article contributions are accrued to its participating partner institutions below.